Verily Health Secures New Investment From NVIDIA and CU Healthcare Innovation Fund

Verily Health Inc. has announced new strategic investment backing from NVIDIA, extending its March funding round. Existing backer CU Healthcare Innovation Fund II, LP also participated with an additional investment, joining Verily's established investor roster which includes Alphabet, Series X Capital, and UCHealth. The fresh capital will accelerate the precision health AI strategy at Verily, specifically supporting the scaling and enterprise adoption of its flagship Verily Pre Platform and patient engagement tool Verily Me. The Verily Pre Platform assists healthcare and life sciences organizations in transforming complex data into AI-ready formats and deploying models responsibly across clinical workflows. This investment deepens an ongoing collaboration between Verily and NVIDIA established in October 2025. Researchers utilizing Verily's platform leverage NVIDIA's full AI stack, including NVIDIA B200 GPUs, NeMo, Parabricks, and RAPIDS libraries. The collaboration previously yielded Forecast 1.0, a genomics and electronic health records foundation model delivering enhanced predictive performance and computational efficiency.